Diet and Hypertension Management in African Americans With Chronic Kidney Disease
Chronic Kidney Diseases, High Blood Pressure
About this trial
This is an interventional treatment trial for Chronic Kidney Diseases focused on measuring Racial disparities, Hypertension, Diet, Kidney disease
Eligibility Criteria
Inclusion Criteria:
- Black race (self-identified)
- ≥21 years old
- CKD defined as an eGFR of 30-59 ml/min/1.73m2
Exclusion Criteria:
- History of kidney transplant
- Pregnant of breast-feeding
- Risk factors for hyperkalemia including insulin-dependent diabetes mellitus, diabetes with poor blood glucose control (A1C >10), baseline serum potassium ≥4.8 mg/dl, and serum bicarbonate <18 mg/dl
- History of hypertension in the preceding 6 months defined as serum potassium greater than 5.1 mg/dl
- Risk for hypotension or severe hypertension (SBP <120 or ≥180 or DBP ≥110 mmHg)
- History of kidney transplant
- Lack of English language proficiency
Sites / Locations
- Duke University Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Other
Behavioral Diet Counseling
Standard of Care
Groups of 4-6 participants will attend 12 weekly dietitian-led counseling sessions and receive coaching on practical strategies to enhance DASH diet adherence and reduce daily sodium intake.
Participants will meet one-on-one with the study dietitian for a single 30- minute encounter and be advised to limit daily sodium intake per current clinical practice guidelines for hypertension in patients with CKD. Educational handouts and tip sheets about practical strategies to reduce dietary sodium will be distributed.